Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4HCF7
Term | Name | Level | Count |
---|---|---|---|
GO:0006518 | peptide metabolic process | 4 | 14 |
GO:0006575 | cellular modified amino acid metabolic process | 3 | 14 |
GO:0006749 | glutathione metabolic process | 4 | 14 |
GO:0006751 | glutathione catabolic process | 5 | 14 |
GO:0006790 | sulfur compound metabolic process | 3 | 14 |
GO:0006807 | nitrogen compound metabolic process | 2 | 14 |
GO:0008152 | metabolic process | 1 | 14 |
GO:0009056 | catabolic process | 2 | 14 |
GO:0009987 | cellular process | 1 | 14 |
GO:0042219 | cellular modified amino acid catabolic process | 4 | 14 |
GO:0043171 | peptide catabolic process | 4 | 14 |
GO:0043603 | amide metabolic process | 3 | 14 |
GO:0044237 | cellular metabolic process | 2 | 14 |
GO:0044248 | cellular catabolic process | 3 | 14 |
GO:0044273 | sulfur compound catabolic process | 4 | 14 |
GO:0071704 | organic substance metabolic process | 2 | 14 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 14 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 14 |
GO:1901575 | organic substance catabolic process | 3 | 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0003839 | gamma-glutamylcyclotransferase activity | 5 | 14 |
GO:0016829 | lyase activity | 2 | 14 |
GO:0016840 | carbon-nitrogen lyase activity | 3 | 14 |
GO:0016842 | amidine-lyase activity | 4 | 14 |
GO:0061928 | glutathione specific gamma-glutamylcyclotransferase activity | 5 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 168 | 172 | PF00656 | 0.436 |
CLV_PCSK_KEX2_1 | 56 | 58 | PF00082 | 0.284 |
CLV_PCSK_PC1ET2_1 | 56 | 58 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 259 | 263 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.273 |
DEG_APCC_DBOX_1 | 230 | 238 | PF00400 | 0.547 |
DOC_CDC14_PxL_1 | 134 | 142 | PF14671 | 0.375 |
DOC_CYCLIN_RxL_1 | 256 | 266 | PF00134 | 0.510 |
DOC_PP4_FxxP_1 | 18 | 21 | PF00568 | 0.540 |
DOC_PP4_FxxP_1 | 94 | 97 | PF00568 | 0.443 |
DOC_USP7_MATH_1 | 224 | 228 | PF00917 | 0.473 |
DOC_WW_Pin1_4 | 141 | 146 | PF00397 | 0.534 |
LIG_14-3-3_CanoR_1 | 119 | 125 | PF00244 | 0.505 |
LIG_14-3-3_CanoR_1 | 75 | 80 | PF00244 | 0.473 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.609 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.535 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.547 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.431 |
LIG_LIR_Apic_2 | 154 | 159 | PF02991 | 0.457 |
LIG_LIR_Apic_2 | 16 | 21 | PF02991 | 0.560 |
LIG_LIR_Gen_1 | 105 | 114 | PF02991 | 0.548 |
LIG_LIR_Gen_1 | 232 | 241 | PF02991 | 0.518 |
LIG_LIR_Gen_1 | 25 | 36 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 105 | 110 | PF02991 | 0.548 |
LIG_LIR_Nem_3 | 114 | 120 | PF02991 | 0.535 |
LIG_LIR_Nem_3 | 232 | 236 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.341 |
LIG_PDZ_Class_1 | 275 | 280 | PF00595 | 0.616 |
LIG_Pex14_1 | 38 | 42 | PF04695 | 0.475 |
LIG_SH2_CRK | 117 | 121 | PF00017 | 0.518 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.375 |
LIG_SH2_CRK | 33 | 37 | PF00017 | 0.474 |
LIG_SH2_CRK | 55 | 59 | PF00017 | 0.464 |
LIG_SH2_NCK_1 | 117 | 121 | PF00017 | 0.461 |
LIG_SH2_STAP1 | 48 | 52 | PF00017 | 0.521 |
LIG_SH2_STAT3 | 14 | 17 | PF00017 | 0.600 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.463 |
LIG_SH2_STAT5 | 233 | 236 | PF00017 | 0.475 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.494 |
LIG_SH3_1 | 179 | 185 | PF00018 | 0.375 |
LIG_SH3_1 | 67 | 73 | PF00018 | 0.493 |
LIG_SH3_2 | 70 | 75 | PF14604 | 0.493 |
LIG_SH3_2 | 97 | 102 | PF14604 | 0.547 |
LIG_SH3_3 | 179 | 185 | PF00018 | 0.524 |
LIG_SH3_3 | 223 | 229 | PF00018 | 0.375 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.467 |
LIG_SH3_3 | 94 | 100 | PF00018 | 0.516 |
LIG_WRC_WIRS_1 | 20 | 25 | PF05994 | 0.465 |
MOD_CDK_SPK_2 | 141 | 146 | PF00069 | 0.392 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.524 |
MOD_CK1_1 | 147 | 153 | PF00069 | 0.559 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.449 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.518 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.274 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.274 |
MOD_GlcNHglycan | 268 | 272 | PF01048 | 0.479 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.588 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.674 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.375 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.492 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.472 |
MOD_GSK3_1 | 215 | 222 | PF00069 | 0.487 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.499 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.491 |
MOD_N-GLC_1 | 132 | 137 | PF02516 | 0.324 |
MOD_N-GLC_1 | 162 | 167 | PF02516 | 0.318 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.410 |
MOD_NEK2_1 | 237 | 242 | PF00069 | 0.574 |
MOD_PK_1 | 102 | 108 | PF00069 | 0.375 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.446 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.591 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.410 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.516 |
MOD_Plk_4 | 32 | 38 | PF00069 | 0.481 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.475 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.466 |
MOD_ProDKin_1 | 141 | 147 | PF00069 | 0.534 |
TRG_DiLeu_BaEn_2 | 231 | 237 | PF01217 | 0.495 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.493 |
TRG_ENDOCYTIC_2 | 233 | 236 | PF00928 | 0.518 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.474 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.464 |
TRG_ER_diArg_1 | 262 | 265 | PF00400 | 0.476 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P815 | Leptomonas seymouri | 64% | 100% |
A0A1X0NTG7 | Trypanosomatidae | 44% | 100% |
A0A3Q8ILN3 | Leishmania donovani | 61% | 100% |
A0A3R7NMW8 | Trypanosoma rangeli | 44% | 100% |
A0A3S5H7B1 | Leishmania donovani | 85% | 100% |
A4HZZ0 | Leishmania infantum | 61% | 100% |
A4HZZ1 | Leishmania infantum | 84% | 87% |
B3STU3 | Rattus norvegicus | 33% | 100% |
C9ZSN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AVV1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 100% |
E9AVV2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 87% |
P32656 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
P87305 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 28% | 100% |
Q4QBM7 | Leishmania major | 81% | 100% |
Q4QBM8 | Leishmania major | 61% | 90% |
Q84QC1 | Arabidopsis thaliana | 33% | 100% |
Q8R3J5 | Mus musculus | 33% | 100% |
Q9BUX1 | Homo sapiens | 32% | 100% |